Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The inflammation pathway (non-prostaglandin mediated) refers to the complex network of cellular and molecular events involved in the inflammatory response, excluding those directly reliant on prostaglandin synthesis. This pathway involves cytokines (e.g., IL-1, TNF-α, IL-6), chemokines (e.g., CXCL8, CCL2), the complement system, kinins, nitric oxide, reactive oxygen species, and intracellular signaling cascades like NF-κB, MAPK, and JAK/STAT. Receptors such as TLRs, CLRs, and NLRs recognize pathogens and activate downstream signaling. Resolution of inflammation is crucial for tissue homeostasis and involves mediators like lipoxins, resolvins, and protectins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inflammation Pathway (Non-Prostaglandin Mediated).